WinstonWınston
Back
Hinge Health logo

Hinge Health

HNGE
67
Medical - Healthcare Information Services · Healthcare
Winston Score
67
Winston is curious
A decent business — some strong pillars, some weaker.
Data as of Aug 23, 2026 · filings through Jun 30, 2026
How the score breaks down
Quality
Exceptional
Growth
Good
Cash Flow
Exceptional
Stability
Good
Valuation
Good

Winston Score History

The full picture

Hinge Health is a digital health company that helps people manage chronic musculoskeletal pain — things like back pain, knee pain, and hip pain — without surgery or heavy medication. It sells its program to employers and health insurance plans, who then offer it as a benefit to their employees or members. The company operates mainly in the United States and is one of the larger digital physical therapy platforms in the country.

Hinge Health makes money by charging employers and insurers a per-member fee to access its app-based exercise therapy program, which includes wearable sensors and virtual coaching from physical therapists. Its 80% gross margin reflects the scalable, software-driven nature of the business, but the company is currently spending far more than it earns, resulting in deep operating losses. The key question going forward is whether Hinge Health can grow its customer base fast enough to reach profitability before it needs to raise more capital.

Growth Profile

When traditional metrics don't capture the full picture, these are the signals growth stock investors use instead.

Revenue Growth

+53.0% YoY

YoY Growth Rate

Revenue accelerating

EPS Growth

+107.5% YoY

YoY Growth Rate

EPS growth accelerating

Insider Activity

5.2%ownership

Flat

Insider ownership roughly steady over the past year

Cash Position

Cash flow positive

$474M cash & investments

Quarterly Free Cash Flow

↑ Burn rate improving

Company generates more cash than it spends — no dilution risk from fundraising

Revenue accelerating

Hinge Health grew revenue 53% year-over-year and the growth rate is speeding up. That's the kind of momentum growth investors look for — the question is whether margins can follow.

The Winston Score above measures business quality today. Growth stocks often score lower because they invest in the future rather than maximising current profits. These metrics show what matters most for evaluating that future.

Score breakdown

Every number that matters to educated investors.

Each metric is explained in plain language so you know exactly what you're looking at. Start your free trial now.

Quality

Profit per sale
Gross Margin
86.4%
Premium pricing power — 86.4% gross margin
Profit after running costs
Operating Margin
19.0%
Healthy — 19.0% operating margin
Return on the money invested
ROCE
27.2%
Exceptional — 27.2% return on capital

ROIC above 25%. Every dollar invested in the business earns more than 25 cents back per year.

Full breakdown available with your free trial

See every metric, trend, and what it means for this stock.

Try free

Growth

Sales growth
Sales YoY
+49.8%
Fast-growing sales (+49.8% YoY)
Profit growth
EPS YoY
N/A
Data not available
How steady the profit is
EPS Consistency
5/8 quarters
Mixed — about half the quarters showed growth

Full breakdown available with your free trial

See every metric, trend, and what it means for this stock.

Try free

Cash Flow

Profit that turns into cash
Cash Conversion
267%
Turns 267% of profit into real cash
Spare cash per sale
FCF Margin
39.9%
Converts sales into free cash efficiently (39.9%)

Free cash flow margin above 20%. Out of every $100 in sales, more than $20 is real cash they keep.

Full breakdown available with your free trial

See every metric, trend, and what it means for this stock.

Try free

Stability

What it owes vs what it owns
Debt / Equity
N/A
Data not available
Covers its interest
Interest Cover
100.00x
Comfortably covers interest (100.0x)

Interest coverage above 8. Profits cover interest many times over.

Full breakdown available with your free trial

See every metric, trend, and what it means for this stock.

Try free

Valuation

Price vs profit
P/E Ratio (TTM)
65.7x
no trend
Expensive — P/E 65.7

P/E over 35. The market is pricing in heavy, sustained growth.

Cheaper or dearer next year
P/E vs Forward
+48.9
GROWING
Earnings expected to grow meaningfully — cheaper on forward P/E (65.7 → 16.7)

Full breakdown available with your free trial

See every metric, trend, and what it means for this stock.

Try free

Dividends

Not applicable for this business.
🔒 See full fundamentals and if they are improving or declining — click here for your free trial now.
Start free trial